Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma—a multicenter analysis of the German working group “Stereotactic Radiotherapy”

BACKGROUND: Renal cell carcinoma (RCC) is traditionally considered to be radioresistant. Radiotherapy response rates are believed to improve with hypofractionated, high dose stereotactic body radiotherapy (SBRT). However, limited data exist regarding the role of SBRT in the treatment of pulmonary me...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Thorac Dis
Asıl Yazarlar: Hoerner-Rieber, Juliane, Duma, Marciana, Blanck, Oliver, Hildebrandt, Guido, Wittig, Andrea, Lohaus, Fabian, Flentje, Michael, Mantel, Frederick, Krempien, Robert, Eble, Michael J., Kahl, Klaus Henning, Boda-Heggemann, Judit, Rieken, Stefan, Guckenberger, Matthias
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721071/
https://ncbi.nlm.nih.gov/pubmed/29268521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.10.108
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller